Fisher Asset Management’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
Other funds holding CADL
ACA
SVCM
Fisher Asset Management's CADL Position: Q3 2026 in Review
Fisher Asset Management held its Candel Therapeutics (CADL) position steady in Q3 2026 at 57,800 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #776.
Fisher Asset Management first reported a position in CADL in Q2 2026 and has held it in 2 quarters since. 141 funds tracked by Wall St. Rank hold CADL as of Q3 2026.
- Fisher Asset Management held 57,800 shares of Candel Therapeutics worth $603K as of Q3 2026.
- Fisher Asset Management left its Candel Therapeutics share count unchanged in Q3 2026.
- Candel Therapeutics made up ﹤0.01% of Fisher Asset Management's portfolio in Q3 2026, its #776 holding.
- Fisher Asset Management first reported a position in Candel Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 141 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.
Based on Fisher Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.